Paolo Di Bartolomeo

Paolo Di Bartolomeo

UNVERIFIED PROFILE

Are you Paolo Di Bartolomeo?   Register this Author

Register author
Paolo Di Bartolomeo

Paolo Di Bartolomeo

Publications by authors named "Paolo Di Bartolomeo"

Are you Paolo Di Bartolomeo?   Register this Author

34Publications

890Reads

10Profile Views

Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.

Biol Blood Marrow Transplant 2018 06 2;24(6):1223-1231. Epub 2018 Feb 2.

Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy; Department of Pediatric Sciences, University of Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.01.022DOI Listing
June 2018

Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models.

Biol Blood Marrow Transplant 2017 Nov 17;23(11):1847-1851. Epub 2017 Jul 17.

Department of Hematology, Transfusion Medicine and Biotechnologies, Ospedale Civile, Pescara, Italy; Department of Medicine and Aging Sciences, University of Chieti-Pescara, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.07.009DOI Listing
November 2017

Sensitivity of cutaneous chronic myelomonocytic leukaemia lesions to hypomethylating treatment.

Eur J Dermatol 2017 10;27(5):540-542

Institute of Hematology and Hemato-Oncology Research Centre (CREO), University of Perugia, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/ejd.2017.3068DOI Listing
October 2017

Hospital discharge records as data source to monitor epidemiologic indicators of hematologic malignancies in Abruzzo.

Tumori 2016 Jun 22;2016(3):258-63. Epub 2016 Feb 22.

Department of Hematology, Transfusion Medicine and Biotechnology, ASL of Pescara, Regional Authority of Abruzzo, Pescara - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000472DOI Listing
June 2016

Visceral leishmaniasis in relapsed and overtreated multiple myeloma in the era of high dose and "novel agent" therapy.

Int J Hematol 2015 Oct 10;102(4):391-3. Epub 2015 Sep 10.

Clinical Hematology, Department of Hematology, Transfusion Medicine and Biotechnology, "Spirito Santo" Civic Hospital, Pescara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1863-4DOI Listing
October 2015

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.

Neurology 2015 Mar 11;84(10):981-8. Epub 2015 Feb 11.

From the MRI Center for Neurological Diseases (L.R.), Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health (G.L.M., D.C.), and the Biostatistic Unit, Department of Health Sciences (M.P.S., L.R.), University of Genova; the Bone Marrow Transplantation Unit (F.G.), S. Martino Hospital, Genova, Italy; the Service of Neurology (A.S.) and the Hematology Department (E.C.), Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer, Hospital Clínic, University of Barcelona, Spain; the Department of Neurosciences (E.M.) and the Bone Marrow Transplantation Unit, Department of Hematology and Oncology (A.D.), University of Modena and Reggio Emilia; the MS Center, Department of Neuroscience, Imaging and Clinical Sciences (A.L.), University Gabriele D'Annunzio, Chieti-Pescara; the Bone Marrow Transplant Center, Department of Hematology (P.D.B.), Spirito Santo Hospital, Pescara; the Multiple Sclerosis Unit Ospedale Papa Giovanni XXIII (M.R.R.), Bergamo; the Hematology and Bone Marrow Transplant Unit Azienda Ospedaliera Papa Giovanni XXIII (A.R.), Bergamo; Division Neurology 1 (M.P.A.) and Division Neurology 2, Drug and Child Health (L.M., L.V.), Department of Neurosciences, and Bone Marrow Transplantation Unit (M.D.G., R.S.), Careggi University Hospital, University of Firenze; the Neuroimaging Research Unit (M.F.), Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan; the Department of Medical and Surgical Sciences (U.A.), Magna Graecia University of Catanzaro; the Advanced Cellular Therapy Center IRCCS "Istituto Tumori Giovanni Paolo II" Bari (P.I.), Italy; and the Internal Medicine and Vascular Disease Unit (D.F.), Assistance Publique Hospitaux de Paris (AP-HP) INSERM U 796, Paris 7 University, Saint-Louis Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001329DOI Listing
March 2015

Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients.

Am J Hematol 2008 Sep;83(9):717-20

Unità Operativa Ematologia e Centro Trapianti Wilma Deplano Ospedale Oncologico Armando Businco, Cagliari.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21240DOI Listing
September 2008

Graft versus host disease-related Hafnia alvei colonization and probable infection.

J Med Microbiol 2008 Sep;57(Pt 9):1167-9

Clinical Microbiology and Virology Unit, Department of Transfusion Medicine, Spirito Santo Hospital, Via Fonte Romana 8, 65100 Pescara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1099/jmm.0.2008/001164-0DOI Listing
September 2008

Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation.

Am J Hematol 2008 Jul;83(7):528-30

Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico, Dipartimento di Ematologia, Ospedale Civile, Pescara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21175DOI Listing
July 2008